Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing

Inflammatory conditions can lead to debilitating and persistent pain. This hyperalgesia reflects sensitization of peripheral terminals and facilitation of pain signaling at the spinal level. Studies of peripheral systems show that tissue injury triggers not only inflammation but also a well-orchestrated series of events that leads to reversal of the inflammatory state. In this regard, lipoxins represent a unique class of lipid mediators that promote resolution of inflammation. The antiinflammatory role of peripheral lipoxins raises the hypothesis that similar neuraxial systems may also down-regulate injury-induced spinal facilitation of pain processing. We report that the lipoxin A4 receptor is expressed on spinal astrocytes both in vivo and in vitro and that spinal delivery of lipoxin A4, as well as stable analogues, attenuates inflammation-induced pain. Furthermore, activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase in astrocytes, which has been indicated to play an important role in spinal pain processing, was attenuated in the presence of lipoxins. This linkage opens the possibility that lipoxins regulate spinal nociceptive processing though their actions upon astrocytic activation. Targeting mechanisms that counterregulate the spinal consequences of persistent peripheral inflammation provide a novel endogenous mechanism by which chronic pain may be controlled.

[1]  C. Serhan,et al.  Cutting Edge: Nociceptin Stimulates Neutrophil Chemotaxis and Recruitment: Inhibition by Aspirin-Triggered-15-Epi-Lipoxin A41 , 2001, The Journal of Immunology.

[2]  F. Cunha,et al.  Antinociceptive Effects of Interleukin-4, -10, and -13 on the Writhing Response in Mice and Zymosan-Induced Knee Joint Incapacitation in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[3]  J. Calixto,et al.  Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin. , 2006, Prostaglandins & other lipid mediators.

[4]  Kirk W. Johnson,et al.  Controlling pathological pain by adenovirally driven spinal production of the anti‐inflammatory cytokine, interleukin‐10 , 2005, The European journal of neuroscience.

[5]  J. Eisenach,et al.  Spinal glial activation contributes to postoperative mechanical hypersensitivity in the rat. , 2006, The journal of pain : official journal of the American Pain Society.

[6]  J. Deleo,et al.  Acute peripheral inflammation induces moderate glial activation and spinal IL-1β expression that correlates with pain behavior in the rat 1 Published on the World Wide Web on 17 March 1999. 1 , 1999, Brain Research.

[7]  S. Maier,et al.  Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat , 1997, Pain.

[8]  C. Serhan,et al.  Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils. , 1992, The Journal of biological chemistry.

[9]  C. Woolf,et al.  ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model , 2005, Pain.

[10]  C. Svensson,et al.  Intrathecal minocycline attenuates peripheral inflammation‐induced hyperalgesia by inhibiting p38 MAPK in spinal microglia , 2005, The European journal of neuroscience.

[11]  C. Sommer,et al.  Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. , 2006, Arthritis and rheumatism.

[12]  Charles N. Serhan,et al.  Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.

[13]  C. Serhan,et al.  Activation of Lipoxin a4 Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation , 2000, The Journal of experimental medicine.

[14]  C. Serhan,et al.  Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor , 1994, The Journal of experimental medicine.

[15]  Stephen B. McMahon,et al.  Immune and glial cell factors as pain mediators and modulators , 2005, Experimental Neurology.

[16]  J. Deleo,et al.  Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. , 2001, The Journal of pharmacology and experimental therapeutics.

[17]  W. Gong,et al.  Expression of functional formyl peptide receptors by human astrocytoma cell lines , 2000, Journal of Neuroimmunology.

[18]  T. Takano,et al.  Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors , 1997, The Journal of experimental medicine.

[19]  I. Decosterd,et al.  A Peptide c-Jun N-Terminal Kinase (JNK) Inhibitor Blocks Mechanical Allodynia after Spinal Nerve Ligation: Respective Roles of JNK Activation in Primary Sensory Neurons and Spinal Astrocytes for Neuropathic Pain Development and Maintenance , 2006, The Journal of Neuroscience.

[20]  T. Yaksh,et al.  Characterization of time course of spinal amino acids, citrulline and PGE2 release after carrageenan/kaolin-induced knee joint inflammation: a chronic microdialysis study , 1996, Pain.

[21]  C. Serhan Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.